Venue: COEX Conference Room, 3F
Panel
AI Session: Variational AI & Mila
We All Have AI. Now What? : Building Real Value in AI Drug Discovery
Speaker / organization: ■ Moderator and Panelists • Moderator: Handol Kim, CEO, Variational AI • Laurent Tillement, Director partnershps, AI & Health, MILA • Jue Wang, Head of Business Development, Insilico Medicine : global partnering and BD experience in translating AI-driven platforms and assets into pharma collaborations and deals • Taeyoung Park, CEO, Galux : AI-based protein design and biologics discovery, representing a newer generation of promising AI biotech companies • Sangwook Woo, CEO, PharmCADD : AI and ph